Ditemukan 1 dokumen yang sesuai dengan query
This book reports on CXCR4 antagonists, an exciting new class of compounds that aid in use of stem cells for treatment of leukemia and other cancers. Includes coverage of plerixafor, now approved for stem cell mobilization of lymphoma and myeloma patients...
New York: Springer, 2012
e20401694
eBooks Universitas Indonesia Library
